0

Journal Articles

in Parkinson Disease/Parkinsonian Disorders
 1-20 of 51 Articles
Health Agencies Update |  February 27, 2013
Parkinson Biomarker Program
Bridget M. Kuehn, MSJ
JAMA. 2013;309(8):759. doi:10.1001/jama.2013.1276.
Lab Reports |  February 06, 2013
Restoring the Blood-Brain Barrier
Tracy Hampton, PhD
JAMA. 2013;309(5):431. doi:10.1001/jama.2013.267.
Clinical Crossroads |  June 06, 2012
Treatment of Parkinson Disease:  A 64-Year-Old Man With Motor Complications of Advanced Parkinson Disease
Daniel Tarsy, MD
JAMA. 2012;307(21):2305-2314. doi:10.1001/jama.2012.4829.
INCLUDES: CME , Supplemental Content
Lab Reports |  March 07, 2012
Parkinson Disease Protein
Tracy Hampton, PhD
JAMA. 2012;307(9):904. doi:10.1001/jama.2012.224.
Medical News and Perspectives |  August 24, 2011
Meth Use Linked to Risk of Parkinson Disease
Bridget M. Kuehn
JAMA. 2011;306(8):814. doi:10.1001/jama.2011.1205.
Health Agencies Update |  March 23, 2011
Parkinson Disease and Pesticides
Bridget M. Kuehn
JAMA. 2011;305(12):1188. doi:10.1001/jama.2011.318.
Clinical Crossroads |  March 09, 2011
Impaired Driving From Medical Conditions:  A 70-Year-Old Man Trying to Decide if He Should Continue Driving
Matthew Rizzo, MD
JAMA. 2011;305(10):1018-1026. doi:10.1001/jama.2011.252.
INCLUDES: CME
Medical News and Perspectives |  September 22, 2010
Troubled by “Stem Cell Tourism” Claims, Group Launches Web-Based Guidance
Mike Mitka
JAMA. 2010;304(12):1315-1316. doi:10.1001/jama.2010.1329.
Health Agencies Update |  June 23, 2010
Stem Cells Boost Dopamine
Bridget M. Kuehn
JAMA. 2010;303(24):2464. doi:10.1001/jama.2010.837.
Lab Reports |  June 02, 2010
Parkinson Disease Insights
Tracy Hampton, PhD
JAMA. 2010;303(21):2129. doi:10.1001/jama.2010.685.
Health Agencies Update |  February 24, 2010
Agent Orange Effects
Bridget M. Kuehn
JAMA. 2010;303(8):722. doi:10.1001/jama.2010.165.
Lab Reports |  May 06, 2009
Spinal Stimulation
Bridget M. Kuehn
JAMA. 2009;301(17):1758. doi:10.1001/jama.2009.570.
Lab Reports |  February 04, 2009
Recycling Woes
M. J. Friedrich
JAMA. 2009;301(5):477. doi:10.1001/jama.2009.42.
Editorial |  January 07, 2009
Neurostimulation for Parkinson Disease
Günther Deuschl, MD, PhD
JAMA. 2009;301(1):104-105. doi:10.1001/jama.2008.938.
Original Contribution |  January 07, 2009 FREE
Bilateral Deep Brain Stimulation vs Best Medical Therapy for Patients With Advanced Parkinson Disease:  A Randomized Controlled Trial
Frances M. Weaver, PhD; Kenneth Follett, MD, PhD; Matthew Stern, MD; et al.
JAMA. 2009;301(1):63-73. doi:10.1001/jama.2008.929.
Medical News & Perspectives |  September 03, 2008
Experts Provide Insights Into Emerging Field of Brain and Spine Repair
Bridget M. Kuehn
JAMA. 2008;300(9):1013-1014. doi:10.1001/jama.300.9.1013.
Lab Reports |  June 04, 2008
Parkinson Treatment
Tracy Hampton, PhD
JAMA. 2008;299(21):2500. doi:10.1001/jama.299.21.2500-c.
The World in Medicine |  May 21, 2008
Parkinson Disease
Joan Stephenson, PhD
JAMA. 2008;299(19):2267. doi:10.1001/jama.299.19.2267-c.
Lab Reports |  October 03, 2007
Parkinson Disease microRNAs
JAMA. 2007;298(13):1506. doi:10.1001/jama.298.13.1506-c.
The World in Medicine |  August 15, 2007
Preventing Neurodegeneration
JAMA. 2007;298(7):731. doi:10.1001/jama.298.7.731-a.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Neurology
Original Contribution  |  May 13, 2013
Clinical and Biochemical Differences in Patients Having Parkinson Disease With vs Without GBA Mutations
Lama M. Chahine, MD; Judy Qiang, BA; Emily Ashbridge; et al.
JAMA Neurology
Editorial  |  March 4, 2013
Lessons for Parkinson Disease From the Parkin Genotype
J. Eric Ahlskog, PhD, MD
JAMA Neurology
Original Contribution  |  March 4, 2013
Parkin Disease:  A Clinicopathologic Entity?
Karen M. Doherty, MRCP; Laura Silveira-Moriyama, PhD; Laura Parkkinen, PhD; et al.
JAMA Neurology
Clinical Trials  |  March 11, 2013
Randomized Controlled Clinical Trial of “Virtual House Calls” for Parkinson Disease
E. Ray Dorsey, MD, MBA; Vinayak Venkataraman, BS; Matthew J. Grana, BA; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems